Eupraxia Pharma (EPRX): Bagan tingkat prakiraan

The stock price action on GURU.Markets for Eupraxia Pharmaceuticals (EPRX), which integrates eco-standards and bioethics into pharmaceutical development, is 15.91. Eupraxia Pharmaceuticals (EPRX) develops analgesics, competing against industry behemoths in this segment while facing risks from high testing costs and generic expansion. Simultaneously, the business is grappling with a liquidity shortage, depleting its reserves and raising investment to cover research and development expenses.

EPRX: Target konsensus Eupraxia Pharma 06.04.2024 - 22.10.2026

Rincian analitis perusahaan Eupraxia Pharmaceuticals (EPRX)

EPRX — sistem indikator bursa lan keuangan eupraxiapharma.com:

Rega bursa eupraxiapharma.com|EPRX - Bagan rega target|Biji pasar Eupraxia Pharma

Analisis umum perusahaan:EPRX Eupraxia Pharmaceuticals, Inc.

Barang unggulan Eupraxia Pharmaceuticals Inc.

The long-term sustainability of Eupraxia Pharmaceuticals (EPRX) is determined by the market's ability to capitalize on DiffuSphere technology by reducing therapy side effects. The average target value on GURU.Markets, reflected in the analytical community's target history, measures the aggregated growth potential of the asset's value, allowing investors to compare fundamental valuation with the company's actual success in commercializing drugs for the management of postoperative pain.

Pesaing Eupraxia Pharmaceuticals

HLN - Rata-rata rega prakiraan|Bagan rega target Kenvue KVUE|VRNA (Verona Pharma PLC) - Bagan tingkat prakiraan|MENS - Bagan rega target|Konsensus nilai wajar LGND (Ligand Corp)|AMRX (Amneal Pharmaceuticals) - Target konsensus|Prakiraan gabungan firma investasi PRGO|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target BioHarvest BHST|Invizyne (EXOZ) - Rata-rata rega prakiraan|ORMP: Target konsensus|Entera Bio Ltd. - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Rata-rata rega prakiraan|RLYB: Target konsensus|LEXX - Prakiraan konsensus analis|Pulmatrix, Inc. (PULM) - Bagan rega target|Bagan tingkat prakiraan PTHL (Pheton Holdings)|Bagan rega target Aptorum Group Ltd|LYRA: Konsensus nilai wajar|Prakiraan konsensus analis IBO|Prakiraan konsensus analis tnfpharma.com (TNFA)|cbdMD - Target konsensus|PRFX: Prakiraan gabungan firma investasi|Auris Medical - Prakiraan konsensus analis|Target median analis Lipella Pharmaceuticals Inc LIPO|OPTN: Prakiraan konsensus analis|Pieris Pharma (PIRS) - Prakiraan konsensus analis|Target konsensus PROC|PTPI: Konsensus nilai wajar|Bagan rega target Qilian International Holding (QLI)|SLRN: Bagan tingkat prakiraan|Prakiraan konsensus analis TFFP (TFF Pharma)